Default Category
-
Measuring Impairment at Dofasco
Mary Gillett; Mary-Jane MastrandreaCase IVEY-9B09B017-EAccounting and ControlIn December 2008, the ArcelorMittal Dofasco (Dofasco) accounting team was facing a significant challenge. In the past few years, Dofasco had undergone significant ownership changes, and when the firm had first been acquired the market had placed a premium share value on the Dofasco subsidiary. In light of a recent economic downturn, the accounting team was required to reassess the values assigned to the subsidiary's net assets. Dismal forecasted ...Starting at €8.20
-
Wattpad
Deighton, John; Kornfeld, LeoraCase HBS-919413-EMarketingHow to run a platform to match 4 million writers of stories to 75 million readers? Use data science. Make money by doing deals with television and film makers and book publishers. The case describes the challenges of matching readers to stories, and of helping writers to produce better stories by supplying feedback on their chapters as they write, all by processing a billion data points daily. But it's hard to acquire new customer groups when alg...Starting at €8.20
-
Rogers Communications, Inc.: The Wave (Spanish Version)
Deighton, John; Voermann, Karsten; Gilyard, ReginaldCase HBS-508S08MarketingRogers Communications, Inc., el mayor proveedor de televisión por cable de Canadá, es decidir cómo debe responder a los acontecimientos que parecen presagiar la convergencia de la industria con las industrias de la informática y de telecomunicaciones. En particular, se está investigando cómo debe probar el mercado de acceso a Internet de alta velocidad a través de módem de cable. Este caso se describen las decisiones que deben hacerse para llevar...Starting at €8.20
-
Accounting at Biovail - Revised
Mary Gillett; Mary-Jane Mastrandrea; Jessica FrischCase IVEY-9B09B004-EAccounting and ControlBiovail was a large international pharmaceutical company with reported revenues of $788 million. Banc of America has issued a research report which indicates that Biovail Corporation's financial statements raised a number of issues that warrant caution for investors, and as a result, Biovail's stock was given a sell rating by Banc of America. A member of Biovail's audit committee is preparing for an upcoming audit meeting and considers the implic...Starting at €8.20